EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 11

Asafoetida Ferula assa-foetida L.

Also called: asafetida, Ferula foetida St.-Lag. (synonym), Scorodosma assa-foetida (L.) H.Karst. (synonym)

Asafoetida is an oleo-gum-resin obtained from the roots of Ferula assa-foetida, a plant native to southern Iran, and is used as a culinary spice. Methemoglobinemia, life-threatening in one case, has been reported in infants given asafoetida as a folk remedy.

Category
Botanical
Part used
Oleo-gum-resin from the root
Strongest evidence
C Limited
Native range
Native to southern Iran (WCVP, the checklist behind POWO: "S. Iran")
Reviewed
2026-10-29

Class 3 Limited studies in people. A 2023 Cochrane review found 1 placebo-controlled RCT (43 participants) of Ferula asafoetida alone for functional dyspepsia. This entry also cites a 2025 placebo-controlled RCT (62 participants) of an asafoetida hydrogel formulation (source 4): 2 RCTs in all. [3]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

2 topics studied1 body area · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Asafoetida does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Asafoetida, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Functional dyspepsia (Cochrane assessment)CA 2023 Cochrane review found one placebo-controlled trial (43 participants): asafoetida may improve dyspepsia symptoms (SMD −1.51), with low-certainty evidence. [3]
Functional dyspepsia symptoms in adultsCA double-blind RCT in 62 participants with functional dyspepsia symptoms (250 mg/day of a hydrogel formulation for 14 days) reported less bloating, early satiety and heartburn than placebo. [4]

Main constituents: Sugars, sesquiterpene coumarins and polysulfides isolated from the oleo-gum-resin [1]; Essential oil of bitter asafoetida from southwest Iran: α-pinene (27.8–38.2%) and (Z)-propenyl sec-butyl disulfide (12.4–24.2%) as main components [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Studied in a trial: 250 mg/day of a self-emulsifying hydrogel formulation of the oleo-gum-resin for 14 days. [4]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • Methemoglobinemia was reported in an infant given the folk remedy glycerited asafoetida (1984 case report). [5]
  • A 2020 case report described life-threatening methemoglobinemia with cyanosis and severe respiratory distress in an infant after asafoetida ingestion; the authors advise avoiding it as a remedy in infants. [6]
  • Localized contact dermatitis has been reported from asafoetida essential oil used as a topical preparation. [7]
Regulation

Regulatory status

  • US: No NDI notification naming asafoetida (Ferula assa-foetida) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. One multi-ingredient entry (NDI 197, submitted 2003-01-22) lists "Resina Ferulae (Chinese asafetida)" without naming Ferula assa-foetida. [8]
  • US food use: 21 CFR 182.20 lists asafetida (Ferula assa-foetida L. and related Ferula species) among essential oils, oleoresins and natural extractives generally recognized as safe for their intended use. [9]
  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed, and that it generally does not approve supplement claims or other labeling before use. [10]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Sesquiterpene coumarins Coumarins (sesquiterpene coumarins) [P1]
  • Polysulfides, e.g. (Z)-propenyl sec-butyl disulfide Organosulfur compounds [P2]
  • α-Pinene (main essential-oil component) Monoterpenes [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming asafoetida (Ferula assa-foetida) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]
  • One multi-ingredient entry (NDI 197, submitted 2003-01-22) lists "Resina Ferulae (Chinese asafetida)" without naming Ferula assa-foetida. [P3]
  • Food use: 21 CFR 182.20 lists asafetida (Ferula assa-foetida L. and related spp. of Ferula) as generally recognized as safe for its intended use. [P4]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of asafoetida (Ferula assa-foetida) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P5]
  • NTP technical reports list checked: no report on asafoetida or Ferula. [P6]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test of each dietary-ingredient lot (at least one appropriate test or examination) — Required for any component that is a dietary ingredient under 21 CFR 111.75(a)(1)(i), unless FDA grants a petition exemption. [P7]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Iranshahy M, Iranshahi M. Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin): a review. J Ethnopharmacol 2011;134(1):1-10 (PMID 21130854), 2011-03-08. pubmed.ncbi.nlm.nih.gov
  2. Karimian V, et al. Chemical composition and biological effects of three different types (tear, paste, and mass) of bitter Ferula assa-foetida Linn. gum. Nat Prod Res 2021;35(18):3136-3141 (PMID 31707845), 2021-09. pubmed.ncbi.nlm.nih.gov
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. eCFR. 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates) (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
  5. IARC Monographs. Agents Classified by the IARC Monographs, Volumes 1–142 (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  6. National Toxicology Program. Technical Reports (list of 2-year studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  7. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
Sources

Sources

  1. Iranshahy M, Iranshahi M. Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin): a review. J Ethnopharmacol 2011;134(1):1-10 (PMID 21130854), 2011-03-08. pubmed.ncbi.nlm.nih.gov
  2. Karimian V, et al. Chemical composition and biological effects of three different types (tear, paste, and mass) of bitter Ferula assa-foetida Linn. gum. Nat Prod Res 2021;35(18):3136-3141 (PMID 31707845), 2021-09. pubmed.ncbi.nlm.nih.gov
  3. Báez G, et al. Non-Chinese herbal medicines for functional dyspepsia. Cochrane Database Syst Rev 2023;6:CD013323 (PMID 37323050), 2023-06-15. pubmed.ncbi.nlm.nih.gov
  4. Das SS, et al. Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore) 2025;104(40):e44590 (PMID 41054174), 2025-10-03. pubmed.ncbi.nlm.nih.gov
  5. Kelly KJ, et al. Methemoglobinemia in an infant treated with the folk remedy glycerited asafoetida. Pediatrics 1984;73(5):717-9 (PMID 6609339), 1984-05. pubmed.ncbi.nlm.nih.gov
  6. Al-Qahtani S, et al. Severe methemoglobinemia secondary to Ferula asafoetida ingestion in an infant: a case report. Saudi J Med Med Sci 2020;8(1):56-59 (PMID 31929780), 2020-01. pubmed.ncbi.nlm.nih.gov
  7. Tempark T, et al. Localized contact dermatitis from Ferula assa-foetida oleo-gum-resin essential oil, a traditional topical preparation for stomach ache and flatulence. Indian J Dermatol Venereol Leprol 2016;82(4):467 (PMID 27279325), 2016-07. pubmed.ncbi.nlm.nih.gov
  8. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  9. eCFR. 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates) (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
  10. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  11. World Checklist of Vascular Plants (WCVP, the taxonomic backbone of POWO), GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2: Ferula assa-foetida L., accepted; distribution "S. Iran"; record links POWO urn:lsid:ipni.org:names:842190-1 (retrieved 2026-10-29), 2026-10-29. api.gbif.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Ashwagandha · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.